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To help support implementation of aligning clinical redesign with payment reforms in practices and
institutions throughout the country, we present two cases from Duke University Health System (“Duke”)
and University of Colorado Hospital (“Colorado”). The studies provide practical solutions for not only
implementing clinical redesign, but also an understanding of how those clinical innovations can be
aligned with alternative payment models. The cases will explore the following questions: What
challenges or problems encouraged the organization to redesign CHF care? How did the organization
select and then align care innovations with payment reforms, including bundled payments and shared
savings? What did the organization identify as key success factors and/or challenges? How did these
changes impact the organization's clinical outcomes or ﬁnancial position? Finally, what lessons would
the organization share with others attempting to implement similar strategies?
& 2014 Elsevier Inc.
1. Background
To help support implementation of aligning clinical redesign with
payment reforms in practices and institutions throughout the coun-
try, we present two cases from Duke University Health System
(“Duke”) and University of Colorado Hospital (“Colorado”). The
studies provide practical solutions for not only implementing clinical
redesign, but also an understanding of how those clinical innovations
can be aligned with alternative payment models. The cases will
explore the following questions: What challenges or problems
encouraged the organization to redesign CHF care? How did the
organization select and then align care innovations with payment
reforms, including bundled payments and shared savings? What did
the organization identify as key success factors and/or challenges?
How did these changes impact the organization's clinical outcomes
or ﬁnancial position? Finally, what lessons would the organization
share with others attempting to implement similar strategies?
1.1. Personal content
Living in the small southern town of Bristol, Tennessee at the
age of 86, Robert Neelley Church takes deep pride in living an
active life, especially after surviving a skin cancer diagnosis. But
recently, Robert's health began to trouble him again. He developed
chest pains and had difﬁculty breathing, putting a damper on his
active lifestyle and routine activities. After consulting with his
primary care physician, Robert was referred to a cardiologist to
take a deeper look at his symptoms. After a few tests, Robert's
cardiologist diagnosed him with mild congestive heart failure
(CHF). After discussions with his physician and nurse about
treatment and recovery options, Robert chose to have open heart
surgery.
After surgery, Robert continued to experience persistent short-
ness of breath, even during mild physical exertion. A sudden
worsening of symptoms almost took Robert to the emergency
room, but instead his family encouraged him to go to the Duke
University Health System's Same Day Access Heart Failure Clinic.
While at the clinic, Robert met with his cardiologist, Dr. Zubin
Eapen, and two nurses. Dr. Eapen spent time with Robert to help
him understand what was happening to his heart and the rest of
his body, and explained how additional treatments and behavior
changes could help ease his symptoms.
A few days after their visits, Robert and his family were happy
to see that his discomfort eased and his symptoms dissipated. But
to this day, Robert and his friends and family play a signiﬁcant role
in managing and treating his chronic and challenging condition.
Robert's story is just one of millions of Americans living with CHF
in the United States.
2. Problem
In this section, we will explore CHF's clinical background.
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2.1. Physiology and symptoms
The average human heart beats four million times per year and
pumps enough blood to ﬁll a modern oil supertanker during a
lifetime. However, over time some individuals may experience
damage to cardiac muscles for a variety of reasons, such as plaque
buildup in the arteries, heart attacks, or infections. This condition
is known as congestive heart failure, a chronic disease with
alternating periods of worsening and stability, with minimal
recovery. Half of patients with CHF will die within ﬁve years of
their diagnosis.1 Treatment often includes a number of medica-
tions and lifestyle modiﬁcations such as reduced sodium intake
and daily physical activity. This unpredictable nature and variation
in severity of symptoms signiﬁcantly impacts the patient's use of
health care services, the intensity of their care, and can often
contribute to preventable hospital readmissions and mortality
rates.
2.2. Epidemiology
CHF prevalence is highest in older patients, who make up a
growing portion of the population (one in 5 Americans will be
older than 65 years of age by 2050). Of all patients hospitalized
with CHF, 75 percent are over the age of 65, and half are over 75.
According to the American Heart Association, nearly 6 million
Americans suffer from CHF, and an additional 555,000 are diag-
nosed each year. This chronic condition accounts for one million
hospitalizations in the U.S. annually, is the leading cause of
hospitalization among adults over the age of 65.2 CHF accounts
for a staggering 17 percent of overall national health expenditures,
$273 billion in direct medical costs, and $172 billion in indirect
costs.3
Many CHF patients also suffer from multiple illnesses or co-
morbidities, often adding to the intensity of their care and
treatment. Studies have shown that nearly 40 percent of CHF
patients have ﬁve or more non-cardiac comorbidities, and account
for 81 percent of the total CHF inpatient days.4 This added
complexity of multiple diseases has major implications for provi-
ders, patients, and their caregivers and families that need to
support them in their daily lives.
3. Solution
3.1. Optimizing CHF care: prevent, manage and stabilize
Clinical approaches to chronic disease management beneﬁt
from a three-pronged approach that addresses (1) patient
behavior; (2) physician or practice-level clinical interventions;
and (3) public policy or population health strategies (Fig. 1.)
3.2. Payment reform
3.2.1. Medicare readmission reduction program
In 2012 through the Affordable Care Act, Medicare began the
Hospital Readmission Reduction Program, which levied penalties
to hospitals with higher-than-expected rates of 30-day readmis-
sion after discharge.5
A hospital with a high proportion of patients readmitted within
a short time frame could be an indication of poor quality of care in
the hospital or a lack of appropriate coordination of post discharge
care.6 It could also be an indication, particularly in an academic
medical center setting, of a lesser opportunity to reduce preven-
table readmissions based on a higher acuity patient population.
Based on a calculation of 2012 revenues and payer mix, Duke
could be at risk for penalties up to $29 million and Colorado could
face up to $7 million (though their rates currently do not merit
penalties).
3.2.2. Alternative payment models
In 2013 the Center for Medicare and Medicaid Innovation
(CMMI), a component of CMS, began offering enrollment in two
optional programs. The programs, Bundled Payment for Care
Improvement (BPCI) Initiative and the Accountable Care Organiza-
tion (ACO)/Medicare Shared Savings Program (MSSP), were attrac-
tive to Duke and Colorado. Each posed speciﬁc risks and beneﬁts,
which ultimately resulted in different choices. Overall, each
organization is dedicated to linking clinical innovations to pay-
ment reforms that encouraged a value-based system – one that
rewards based on quality, outcomes, and reducing inefﬁciencies,
such as preventable readmissions – as opposed to a volume-based
system that is based on number of tests, procedures, etc (Fig. 2).
4. Organizational context
4.1. Duke university health system: the path to accountable care
Duke University Health System is a nonproﬁt, fully integrated
academic health care system comprised of Duke University School
of Medicine, three hospitals, and several primary and specialty
care clinics, home care, hospice, wellness centers, and community-
based clinical partnerships (Fig. 3).
4.1.1. The challenge of care redesign
In the 1990s, Dr. Christopher O'Connor, a cardiologist, ﬁrst
explored challenges providers faced when trying to provide
Fig. 1. Three-pronged optimal care approach.
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quality CHF care. These included (1) Poor coordination of care.
Patients saw primary care physicians, cardiologists, surgeons,
dieticians, social workers, and others, who often failed to commu-
nicate with each other, and only the patient was aware of all the
appointments and tests. (2) No access to outpatient or primary
care. Patients were unsure of whom to reach out to with questions
or concerns, and did not always have access to providers at the
exact time they required care. This fragmentation almost always
resulted in unnecessary emergency room or hospital visits.
(3) Inadequate disease information and guidelines. At the time,
there was very little information about CHF disease management.
Neither professional organizations nor trade groups had issued
CHF treatment guidelines.
To address these challenges, Duke began a program of care
improvement, with three major CHF initiatives that evolved over
the next 15 years, including the Duke Heart Failure Program, the
Heart@Home Initiative, and Same Day Access Clinic.
4.1.2. The Duke heart failure program
Dr. O’Connor received a $100,000 seed grant to create the Duke
Heart Failure Program. The proposed strategy included, a geogra-
phically distinct unit for CHF, multidisciplinary care teams that
included physicians (cardiology, family practice, and internists),
nurses, dieticians, therapists, pharmacists, and administrative
staff, formally deﬁned care guidelines that identify patients based
on New York Health Association (NYHA) functional classiﬁcation,
and an outpatient disease management clinic, which served as the
foundation for the Same Day Access Clinic.
For patients enrolled in the program from July 1998 to April
1999, study data indicated the hospitalization rate decreased from
1.5 to 0 hospitalizations per patient per year while the number of
clinic visits increased from 4.3 to 9.8 clinic visits per patient per
year. Duke saved a median of $8571 in charges per patient per year
as a result of reduced inpatient costs.7
Despite the fact that the program proved successful at reducing
costs, there was no change in their contracts with payers. Fast
forward ten years - in 2011, Dr. Zubin Eapen became involved in
the CHF program leadership, and redoubled delivery reform efforts
after Medicare instituted the Hospital Readmission Reduction
Program in 2012.
4.1.3. Heart@home initiative
To become self-sustaining, the H@H team determined that
preventing 1 readmission every 2 weeks would result in a
1percent reduction in total CHF case costs. This was calculated
by determining the amount at risk due to the 3percent Medicare
Readmission penalty, nearly $30 million a year. The H@H ﬁnancing
model covers the costs of the program intervention and adminis-
tration, with savings accruing to the payers (the total amount of
savings is unknown at the time of publication).
In 2012, with encouragement from Duke Heart Center leader-
ship such as Dr. Bimal Shah, Catherine McCarver, and others
partnered with the Duke Translational Nursing Institute (DTNI)
and Dr. Bradi Granger to obtain $500,000 in grants to fund further
improvements. Speciﬁc changes included: (1) putting in place a
dedicated care team for each patient, (2) improving communica-
tion, (3) coordinating care across all providers and sites of care,
and creating standard protocols for post-discharge processes,
including follow up procedures, ensuring all inpatients discharged
from the hospital had an outpatient follow-up within 1 week, and
(4) patient education and self-care support such as an iPad app,
which captures speciﬁc CHF information that is exchanged with
providers, including an interactive calendar, self-assessments,
education modules, and an online pill box.
4.1.4. Same day access clinic
Duke researchers analyzed an American Heart Association
registry of thousands of Medicare patients, and found that seeing
a doctor within 7 days of a hospitalization signiﬁcantly reduced
the risk of readmission, emphasizing the need to improve post-
discharge care. As a result, the leadership decided to launch a
Same Day Access (SDA) Heart Failure clinic that would allow
patients to see a CHF specialist immediately without an appoint-
ment. The SDA Clinic opened in 2012 and is located in the
cardiology outpatient ofﬁces. This “one-stop shop” provides con-
sistency of care, ensures proper transitions, and assists with
navigating the health system and managing comorbidities.
4.1.5. Outcomes and results
Preventable CHF readmission rates at Duke have gone down
15 percent in the ﬁrst year of the initiative.8 Secondary clinical
outcomes include improved quality of patient care transitions
Fig. 2. Financial impacts and payment models in the context of CHF care.
Metric Duke Colorado
Hospital Revenue $2.54 billion $941 million
Percent of Medicare Patient Revenue 38.1%13 25%14
Percent of Medicaid Patient Revenue 20.9% 10%
Number of residents treated by the hospital 239,358 989,699
Total annual Inpatient admissions 60,596 69,993
Medicare CHF in patients 372 205
Fig. 3. Duke and Colorado ﬁnancial comparison metrics (FY 2011).12,13
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evaluated using measures of communication, patient satisfaction,
and skill-based educational outcomes that include patients' ability
to understand and manage medicines, symptoms, dietary salt
intake, and daily activity.
4.2. Aligning payment reforms: the shared savings ACO model
Duke's physician leadership is committed to improving CHF
delivery and had interest in exploring new payment models.
Ultimately, the Duke care redesign team and senior leaders elected
to enroll in the ACO MSSP. Launched in January 2014, Duke
Connected Care, is a community-based, physician-led MSSP ACO
that includes 1700 doctors from Duke, the Lincoln Community
Health Center, and three other practices to care for a population of
over 45,000 Medicare beneﬁciaries.
4.2.1. Why Duke opted not to pursue a bundled payment for CHF
The economic principle behind a bundle is to separate technical
risk (things clinicians can manage) from probability risks (thing
outside their control), and transfer the former to clinicians and the
latter to insurers. Perhaps one of the most important factors driving
Duke's decision is the inherent variability of CHF; they believe
separating technical from probability risks in CHF would be very
difﬁcult. Duke expressed concern that efforts aimed at decreasing
admissions for CHF might, in a bundled payment, create ﬁnancial
incentives that were misaligned with the goals of improving
patient care. Namely, a shift in volumes to higher-acuity CHF
inpatients might over-emphasize probability risks compared to
prior years. BPCI episodes typically fall into one of two categories-
medical and surgical. Surgical episodes, such as a knee replace-
ment, can be easier to predict and have less variability among the
care needed. Medical episodes, particularly chronic, complex
conditions like CHF, have a much greater range in care needed-
both inpatient and outpatient, which is a key reason the bundles
have not gained widespread traction. The variation in care leads to
extremely high cost cases, that create risk for BPCI participants,
while also creating potential opportunties for savings through
improvements in care delivery.
Duke's leadership in particular believed that a variety of
complicating factors in its patient population could make any
bundle for CHF too risky. One of the greatest strengths of a bundle
is to provide predictability and standardization of care and costs.
Due to the complexity of CHF, medical and support care is not
systematically applied the same way to each patient. Further, CHF
is not an isolated acute care episode with a clear beginning and
end that lends itself to developing a ﬁxed payment per episode. In
addition to the MSSP, Duke did enroll in one BPCI pilot: percuta-
neous cardiac intervention (a procedure used to treat narrowed
arteries in a patient's heart, known as PCI) instead of CHF. This was
a way of “dipping a toe in the water” until better metrics and risk
adjustment can be developed for CHF based on experience mana-
ging the PCI bundle. Unlike a bundle that is procedure oriented
with a well-deﬁned start and episode of care, the chronic nature of
CHF as a disease made an index hospitalization less appealing as a
trigger for a bundled payment. Duke was also unsure if the BPCI's
required 30, 60, or 90-day bundle would be appropriate for CHF
because they hoped to focus on care strategies, such as Heart@H-
ome, that went beyond these time periods to determine the
stability of a discharged CHF patient.
Due to the variety of unknown factors involved, Duke took a
conservative approach. Known CHF costs were indexed in the
inpatient setting. Yet, a large portion of costs and care was
performed in outpatient settings. Such longitudinal, post-acute
care is often performed in rehabilitation centers, community
health centers, and skilled nursing facilities that Duke does not
have control over care and costs. They also did not have enough
evidence that their clinical interventions were effective in redu-
cing CHF costs. Thus, they worried that a large investment of
resources in new delivery models was unlikely to result in
signiﬁcant cost reduction that would reap savings in a bundled
payment setting. In contrast, Duke's participation in the MSSP
program will, in the long term, lead to investment in enhanced
primary care services. This may lead to more fundamental delivery
reform and potential investments in prevention and population
health.
4.3. University of Colorado hospital: the path to bundled Payments
The University of Colorado Hospital is an academic medical
center composed of four campuses and ﬁve hospitals across the
state based in Aurora, CO (Fig. 3). The three major components of
the system are the hospitals, the School of Medicine, and United
Physicians Inc. (UPI), a nonproﬁt organization that supports the
medical operations of Colorado. Elizabeth Kissick, the director of
health plan development for UPI and Dr. Larry Allen, a professor
and cardiologist have been administrative and clinical leaders in
the push toward care and payment redesign, especially for the CHF
population.
4.3.1. The challenge of care redesign
The American College of Cardiology and Institute for Healthcare
Improvement started the national “Hospital to Home,” or H2H
program. This program is a resource for hospitals and cardiovas-
cular care providers committed to improving transitions from
hospital to “home” and reduce their risk of readmission penalties.9
In 2010, Dr. Larry Allen, an advanced CHF and transplant physician,
identiﬁed a need at his own hospital, and started a Colorado-based
H2H in 2010. Like Duke, Colorado has re-engineered its care of
CHF, but with a very speciﬁc focus on using technological
2010:
H2H at 
UCH 
Established
2011:
AAMC 
Convened 
Meeting
2012:
Initiation 
by UCH 
administra
tion
2014: 
BCPI 
launched
Care Innovation
• Real-time identification of CHF 
hospitalizations using manual and EHR 
records
• Standardardized order sets triggered by 
BPA
• Data benchmarks using the Get With the 
Guidelines  and reviewed during H2H 
meetings
• High-risk patient care coordination from a 
CNS
• Eduation-"Heart  Failure University" for 
patients and families
• Follow-up phone calls within 48 hours of 
discharge
Fig. 4. Colorado heart failure innovation timeline.
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innovation to reduce length of inpatient hospitalizations and
reduce readmissions (Fig. 4).
4.3.2. Choosing bundled payments
The team at Colorado prepared an environmental analysis of
payment reform, and for a number of years, was engaged in a
number of Colorado state initiatives for state-wide bundling in
Medicaid and the private sector. Colorado viewed the model as an
expansion of a previous demonstration model – this familiarity
with the payment model and evidence of cost savings helped
minimize the associated risks. Ms. Kissick worked with the
American Association of Medical Colleges (AAMC), a convener
under contract from Medicare to assist with pilot participation, to
create a program to begin in January 2014.
Under the BPCI, participants had the option to choose from one
of four models; Colorado chose a 30-day, model 4 bundle. This
model utilized prospective payments such that the hospital would
receive a single, lump sum payment from Medicare and then
distribute that payment among all of the providers involved in the
episode of care – and if their costs exceed the budget, Colorado
would absorb the extra costs. When compared to fellow BPCI
participants, 116 institutions implemented a CHF bundle, with
Colorado being the only institution to opt for a 30-day model;
others all chose longer time periods (60–90 days).
BPCI makes hospitals ﬁnancially responsible for services pro-
vided if a readmission occurs. For example, CMS would not pay
claims for CHF related services provided at Colorado within 30
days of the anchor hospitalization. In addition, for any CHF-related
services provided at another hospital, Colorado would be ﬁnan-
cially responsible for the total payments made during that
readmission.10
Colorado felt that the 30 day bundle was the best option
because it allows hospitals to begin taking risk for acute-care
services, while they ready themselves to take accountability for
post-acute care services and hospital readmissions. It also sets the
stage to work toward a ﬁxed budget with the prospective
payments – something that will become commonplace sooner
rather than later.11 Colorado only projected an approximate
$40,000 savings in the ﬁrst year of the BPCI. This amount would
cover the discount to CMS and other costs such as the investment
made for data discovery and costs associated with preparing the
application. This small amount relative to overall Colorado rev-
enue, illustrated Colorado's commitment to reform payment
despite a small incentive.
Colorado customized the bundle and gain-sharing structure
that would accommodate their provider expertise, interest, service
mix, and patient population. Colorado proposed which Medicare
services were included and excluded in the bundle. Colorado
estimated that there would be about 100 Medicare patients who
would be discharged with primary diagnosis of heart failure
(based on prior data).
5. Solution and key lessons
There were a number of factors present at both institutions that
were critical to the success of their projects that may be helpful for
other organizations interested in implementing these clinical and
ﬁnancing reforms.
A commitment to continuous improvement in large centers can
ﬂourish in the presence of initially small ﬁnancial incentives. Both
centers made signiﬁcant steps to improve care quality even in
areas where signiﬁcant ﬁnancial gains were not expected (for
example, the upside for Colorado was less than $40,000 per year).
Impact of “demand destruction” on ﬁnancial risk-taking. With
better care coordination, hospital healthcare spending will be
reduced as a result of decreased volume, and this can have a
negative impact on those hospitals' operating margins. Therefore,
bundled payments may not be the best option over long periods, if
the organization cannot adapt their business model to accommo-
date the decrease in revenue.
Clinical leadership is essential to change management and quality
improvement. Duke and Colorado have highly committed clinical
leaders who envisioned and pursued innovative care. The effect of
top-down leadership is essential in supporting a commitment to
continuous quality improvement and a culture of learning and
innovation.
Convening organizations play a key role in providing technical
assistance and implementation support. Clinical leaders and health
systems do not always have a complete set of tools for payment
reform. Thus, conveners contracted by CMMI, played a helpful role
in catalyzing payment reform for their members.
The future of further care redesign is uncertain. While both
organizations began with relatively small-scale, incremental pilot
programs around CHF, it remains to be seen if this will lead to
broader redesign of CHF care. While such changes can be incenti-
vized by shared savings ACOs or bundled payments, time will tell if
the centers pursue more comprehensive, high-value changes
in care.
5.1. Policy recommendations
Create more direct clinician incentives for quality-related out-
comes. For such small changes to lead to larger ones, clinicians
must be rewarded or penalized with clearer connections to clinical
outcomes under their control. This would require the creation of
numerous ﬁnancial “microenvironments” through a large organi-
zation (for example, with partially bundled payments), with well-
designed supportive electronic medical records. This must include
start-up costs for upfront changes in infrastructure.
Improve coordination and best-practice sharing between various
institutions. Though clinical leaders and hospitals each pursued
innovations in care, hospitals appeared to work in isolation with-
out clear standardization or sharing of best practices.
Improve long-term incentives for clinical leaders. A key compo-
nent of sustainability is to provide meaningful recognition to such
clinician leaders in academic and other settings. In addition,
clinicians could perhaps satisfy licensing or board certiﬁcation
requirements with direct, meaningful involvement in delivery
reform. Such innovative uses of recertiﬁcation might create
broader interest in clinical redesign and payment reform.
Rethink existing value-based purchasing (VBP) and pay-for-
performance programs. Neither Duke nor Colorado clinical leaders
reported that these initiatives encouraged strongly enough the
kind of global care redesign that might lead to additional oppor-
tunties for improvement in meaningful long-term outcomes.
A consolidation of the VBP program at some point into the BPCI
or Shared Savings models would be beneﬁcial.
Establish long-term funding for technical assistance and startup
costs. Though convening organization played an important role in
seeding CMMI pilot programs, no long-term, continuing sources of
funding are present. Additionally, these conveners could expand to
cover not only Medicare pilot programs, but also help design
programs targeting and consolidating a health system's private
insurers into such pilots as well, to create ampliﬁed, focused
incentives.
Prioritize simplicity in payment reforms. Perhaps future rounds
of reforms could consider partial bundles for certain episodes,
which are administratively simpler (for example, like hospital
DRGs), and also do not depend on highly complex and labor
intensive analysis. Measures could also be considered to cap total
regulatory and reporting burdens to reasonable levels.
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